ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30312-1g |
|
83777-30-4 |
DAOS
|
0 | C13H20NNaO6S | |
GC30312-10mM(1mLinDMSO) |
|
83777-30-4 |
DAOS
|
0 | C13H20NNaO6S | |
GC30311-50mg |
|
6025-53-2 |
trans-Zeatinriboside
|
0 | C15H21N5O5 | |
GC30311-10mg |
|
6025-53-2 |
trans-Zeatinriboside
|
0 | C15H21N5O5 | |
GC30311-10mM(1mLinDMSO) |
|
6025-53-2 |
trans-Zeatinriboside
|
0 | C15H21N5O5 | |
GC30310-1g |
|
26027-38-3 |
4-Nonylphenol polyethoxylate (4-Nonylphenol polyethoxylate)
|
0 | — | |
GC30309-50mg |
|
95041-90-0 |
Erianin
|
0 | C18H22O5 | |
GC30309-10mg |
|
95041-90-0 |
Erianin
|
0 | C18H22O5 | |
GC30309-5mg |
|
95041-90-0 |
Erianin
|
0 | C18H22O5 | |
GC30309-10mM(1mLinDMSO) |
|
95041-90-0 |
Erianin
|
0 | C18H22O5 | |
GC30308-50mg |
|
68278-23-9 |
Eflornithine hydrochloride (DFMO hydrochloride)
|
0 | C6H13ClF2N2O2 | |
GC30308-10mg |
|
68278-23-9 |
Eflornithine hydrochloride (DFMO hydrochloride)
|
0 | C6H13ClF2N2O2 | |
GC30307-5mg |
|
892664-04-9 |
GSK-269984A
|
0 | C20H14Cl2FNNaO3 | |
GC30307-1mg |
|
892664-04-9 |
GSK-269984A
|
0 | C20H14Cl2FNNaO3 | |
GC30306-500mg |
|
104098-48-8 |
Imazapic
|
0 | C14H17N3O3 | |
GC30306-100mg |
|
104098-48-8 |
Imazapic
|
0 | C14H17N3O3 | |
GC30306-10mM(1mLinDMSO) |
|
104098-48-8 |
Imazapic
|
0 | C14H17N3O3 | |
GC30305-5mg |
|
120406-37-3 |
Jionoside B1
|
0 | C37H50O20 | |
GC30305-1mg |
|
120406-37-3 |
Jionoside B1
|
0 | C37H50O20 | |
GC30304-50mg |
|
6168-83-8 |
(S)-3-Hydroxybutanoic acid ((S)-β-Hydroxybutanoic acid)
|
0 | C4H8O3 | |